key: cord-0942287-kecnvbgi
authors: Fritz, Cassandra D.L.; Sayuk, Gregory S.; Elwing, Jill E.; Wilgus, Nathan C.; Dieckgraefe, Brian K.; Presti, Michael E.
title: Colonoscopy following COVID-19 delays in procedures: risk stratification for procedures is critical
date: 2022-03-03
journal: Gastro Hep Adv
DOI: 10.1016/j.gastha.2022.02.010
sha: 2cef9e7a54001a8f52210bd4580753d4a3e24054
doc_id: 942287
cord_uid: kecnvbgi

nan

In the wake of the coronavirus disease 2019 (COVID-19) pandemic, non-urgent procedures, including colonoscopy, were halted. Significant declines in colorectal cancer (CRC) screening were prominent and concerning. CRC screening volume declined by as much as 90% during early 2020. 1, 2 COVID-19 significantly affected the incidence of new patient encounters for CRC in 2020, with studies citing reductions from 22% to 54%. 1, 3 Declines in screening and diagnostic procedures were multi-factorial, including patient hesitation to present to healthcare facilities, provider precautions, and administration policy changes.

Conservative modeling assessing the effects of COVID-19 on cancer screening has raised emerging concerns, including increased excess death and upstaging of disease through 2030. 4 In addition to expanding CRC screening modalities (i.e., fecal immunochemical testing), shifting efforts to systematically scheduling patients at higher risk could be another essential mitigation strategy to address the likely increased rates of CRC after COVID-19 scheduling delays. 5 The St. Louis Veterans Affairs (VA) Medical Center utilized a risk stratification tool to aid in scheduling delayed endoscopy procedures with hopes to assign endoscopy resources adequately. We aimed to determine the CRC outcomes after implementing our risk stratification triaging system.

We conducted a single-center, retrospective cohort study within the St. Louis VA Medical Center. The COVID-19 pandemic prompted the St. Louis VA to implement an endoscopy triaging system. This event was used as an independent exposure to determine the association between the exposure, defined by two different periods, June J o u r n a l P r e -p r o o f 1, 2019 to August 31, 2019 (pre-COVID) and June 1, 2020 to August 31, 2020 (after COVID-related scheduling delays, referred to as COVID-delayed), and the odds of a pathology-confirmed CRC diagnosis. Patients 18 years or older who had a colonoscopy during each period were included. M.E.P conducted a manual chart review. This study was exempted by the VA institutional review board as a quality improvement initiative.

In March 2020, the St. Louis VA implemented a risk stratification tool to triage endoscopy during the COVID-19 pandemic. This stratification tool included patient risk factors and procedural urgency. 6 Scores greater than 3 were considered appropriate to defer, while patients with scores less than 3 were offered endoscopy scheduling (Table   1 ). Continuous variables were expressed as means ± standard deviations (SD).

Student's t-tests, or Mann Whitney U test when appropriate, were used to compare means. Categorical data were described as proportions. ANOVA, Chi-square test, and Fisher Exact Test, where necessary, were used to determine the unadjusted odds ratio with a 95% confidence interval (CI). A two-sided p-value of <0.05 was considered statistically significant. The analysis was conducted in SPSS 27.0 (IBM).

A total of 852 patients underwent colonoscopy during the pre-COVID era, and 245 patients underwent colonoscopy during the COVID-delayed era. The average pre-COVID age was 63.2 ± 10.5 years, and the average COVID-delayed age was 62.2 ± 12.6 years. The cohorts were similar in race and family history of CRC. Indication for endoscopy differed between pre-COVID and COVID-delayed cohorts, with 26.1% of the pre-COVID cohort undergoing diagnostic endoscopy compared to 85.3% in the COVID-J o u r n a l P r e -p r o o f delayed era. The mean number of days from referral to endoscopy differed between the cohorts and was significantly shorter in the COVID-delayed era (98.1 ± 124.0 days vs.

48.0 ± 51.7 days; p<0.001). Endoscopy timing for just diagnostic colonoscopy demonstrated the pre-COVID cohort still had a longer wait time to endoscopy than the COVID-delayed cohort (59.4± 87.4 days vs. 44.2± 47.4 days; p= 0.02) ( Table 2) .

Of the 852 pre-COVID endoscopy patients, 8 (0.9%) were found to have CRC. In comparison, 9 (3.7%) of the 245 COVID-delayed patients were found to have CRC.

When assessing the odds of CRC for all indications, CRC appeared to be 4.02 (95% CI, 1.54 -10.54) times higher following COVID-related delays. Yet, when assessing only diagnostic colonoscopies, the odds of CRC for pre-COVID (7 of 222; 3.15%) to COVIDdelayed patients (9 of 209; 4.31%) was non-significant (OR=1.38; 95% CI, 0.51 -3.78). COVID-delayed patients had a trend toward stage III/IV diagnoses, but this finding was not statistically significant (pre-COVID 25% vs. 55.5% COVID-delayed; p >0.05). Time to referral did not differ by race or sex (p>0.05). To our knowledge, there were no COVID-19 exposures or positive cases linked to endoscopic procedures.

In this retrospective cohort study utilizing St. Louis VA data, a risk stratification tool appropriately triaged endoscopic resources, likely mitigating the effect of COVID-delays on CRC diagnoses. Due to the implemented triaging process, diagnostic colonoscopies were significantly more likely in the COVID-delayed era, during which the time from referral to endoscopy was significantly shorter. When comparing diagnostic colonoscopies, we did not find an increased odds of CRC after COVID-related delays in J o u r n a l P r e -p r o o f procedures. Our findings echo the importance of triaging endoscopic cases appropriately when resources are limited, or cases are backlogged. With hindsight, the risk of proceeding with diagnostic procedures was deemed appropriate, even in the face of local COVID-19 surges.

Prior studies assessing COVID-related delays on CRC outcomes suggest a negative effect on CRC stage and mortality just after a 4-month delay in endoscopy. 7, 8 Our data support these findings as the upper limit of any delayed procedure was less than 3 months, and we did not identify a significant difference in CRC stage at diagnosis.

Our study has limitations. This study was conducted as a single-center retrospective cohort design with inherent potential biases and less generalizability. Yet, our endoscopic triaging process, weighing patient and procedural factors, appears to have mitigated the early effect of COVID-related delays on CRC diagnoses. This approach was adopted by many VA Medical Centers nationally and may be pertinent to several other practices. : COVID-delayed: All St. Louis VA colonoscopy data from June 2020 after COVID-related delays in procedures. c : Statistically significant difference between the pre-COVID and COVID-delayed groups.

Effects of the COVID-19 pandemic on cancer-related patient encounters

Colorectal cancer screening and COVID-19. The American journal of gastroenterology

Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based study

COVID-19 and cancer

Screening and surveillance colonoscopy and COVID-19: Avoiding more casualties

Report of the WHO-China Joint Mission on Coronavirus Disease

The number of obstructive colorectal cancers in Japan has increased during the COVID-19 pandemic: A retrospective single-center cohort study

Impact of SARS-CoV-2 pandemic on colorectal cancer screening delay: effect on stage shift and increased mortality